CLOVER HEALTH INVESTMENTS, CORP. /DE - Common Stock (CLOV) Institutional Ownership

13F Institutional Holders and Ownership History from Q1 2019 to Q4 2025

Type / Class
Equity / Common Stock
Symbol
CLOV on Nasdaq
Shares outstanding
416,598,522
Price per share
$2.31
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
125,586,570
Total reported value
$295,177,526
% of total 13F portfolios
0%
Share change
-9,685,964
Value change
-$29,001,681
Number of holders
187
Price from insider filings
$2.31
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of CLOVER HEALTH INVESTMENTS, CORP. /DE - Common Stock (CLOV) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BlackRock, Inc. 7.2% $83,180,072 29,813,646 BlackRock, Inc. 30 Jun 2025
VANGUARD GROUP INC 5.8% $67,646,435 24,246,034 The Vanguard Group 30 Jun 2025

As of 31 Dec 2025, 187 institutional investors reported holding 125,586,570 shares of CLOVER HEALTH INVESTMENTS, CORP. /DE - Common Stock (CLOV). This represents 30% of the company’s total 416,598,522 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of CLOVER HEALTH INVESTMENTS, CORP. /DE - Common Stock (CLOV) together control 27% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
BlackRock, Inc. 7.7% 32,280,859 +6.2% 0% $75,860,020
VANGUARD GROUP INC 5.6% 23,485,912 +1.8% 0% $55,191,894
GEODE CAPITAL MANAGEMENT, LLC 2.4% 9,791,208 +0.73% 0% $23,013,307
STATE STREET CORP 2.2% 9,320,183 +4.1% 0% $21,902,430
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 1.1% 4,690,904 +9.8% 0% $11,023,623
RENAISSANCE TECHNOLOGIES LLC 1.1% 4,491,141 -42% 0.02% $10,554,181
PNC Financial Services Group, Inc. 0.9% 3,763,851 -16% 0% $8,845,050
DIMENSIONAL FUND ADVISORS LP 0.87% 3,634,325 +70% 0% $8,541,992
NORTHERN TRUST CORP 0.76% 3,178,430 -5.8% 0% $7,469,311
MORGAN STANLEY 0.62% 2,599,028 +29% 0% $6,107,716
SUSQUEHANNA INTERNATIONAL GROUP, LLP 0.56% 2,325,253 -14% 0.01% $5,464,345
GOLDMAN SACHS GROUP INC 0.43% 1,781,239 +106% 0% $4,185,911
UBS Group AG 0.32% 1,315,324 -42% 0% $3,091,011
Bank of New York Mellon Corp 0.28% 1,172,758 -1.7% 0% $2,755,981
CITADEL ADVISORS LLC 0.28% 1,147,940 -23% 0% $2,697,659
GROUP ONE TRADING LLC 0.26% 1,087,975 -12% 0.08% $2,556,741
Nuveen, LLC 0.21% 883,536 0% 0% $2,076,310
Invesco Ltd. 0.21% 863,197 -9.9% 0% $2,028,513
Swiss National Bank 0.2% 828,400 +2.6% 0% $1,946,740
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC 0.19% 779,801 +17% 0% $1,832,533
Soviero Asset Management, LP 0.18% 750,000 -46% 0.92% $1,762,500
PRINCIPAL FINANCIAL GROUP INC 0.17% 709,482 +46% 0% $1,667,282
IMC-Chicago, LLC 0.15% 642,964 -25% 0.03% $1,510,965
BARCLAYS PLC 0.15% 637,279 +10% 0% $1,497,605
DEUTSCHE BANK AG\ 0.15% 614,952 +2.4% 0% $1,445,137

Institutional Holders of CLOVER HEALTH INVESTMENTS, CORP. /DE - Common Stock (CLOV) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 125,586,570 $295,177,526 -$29,001,681 $2.35 187
2025 Q3 135,271,235 $413,882,154 -$32,444,876 $3.06 199
2025 Q2 146,128,655 $407,670,376 +$107,801,104 $2.79 197
2025 Q1 105,851,444 $380,012,727 +$48,891,922 $3.59 197
2024 Q4 92,775,680 $292,290,234 +$33,084,501 $3.15 173
2024 Q3 82,031,282 $231,318,941 +$27,492,527 $2.82 154
2024 Q2 73,223,084 $90,062,636 -$13,953,079 $1.23 121
2024 Q1 89,442,327 $71,016,376 -$5,911,907 $0.79 132
2023 Q4 96,511,448 $91,887,186 +$2,277,396 $0.95 141
2023 Q3 93,620,098 $101,107,320 -$3,078,475 $1.08 138
2023 Q2 96,771,026 $86,789,528 -$22,993,945 $0.90 140
2023 Q1 122,809,816 $103,788,732 -$1,403,557 $0.85 150
2022 Q4 126,098,230 $117,195,358 +$72,200 $0.93 167
2022 Q3 123,383,724 $209,751,673 -$931,167 $1.70 150
2022 Q2 122,450,162 $262,010,857 +$44,394,028 $2.14 156
2022 Q1 99,563,575 $353,476,882 -$114,782,509 $3.55 147
2021 Q4 130,139,458 $484,243,395 +$81,897,100 $3.72 144
2021 Q3 105,648,029 $780,734,717 -$325,418,528 $7.39 131
2021 Q2 141,911,833 $1,889,729,052 -$201,269,843 $13.32 132
2021 Q1 160,035,962 $1,206,298,896 +$1,205,006,987 $7.56 118
2020 Q4 74,874 $1,256,000 +$837,000 $16.76 9
2020 Q3 0 $0 -$113,000 $3.75 0
2020 Q2 $3.75 0
2020 Q1 15,000 $113,000 $7.53 1
2019 Q4 $3.75 0
2019 Q3 $3.75 0
2019 Q2 $3.75 0
2019 Q1 $3.75 0